Results 271 to 280 of about 9,406,168 (354)
ABSTRACT There is evidence that persistent dysregulation of the immune system caused by SARS‐CoV‐2 infection may increase susceptibility to other infections. Here, we assessed whether it is associated with subsequent diagnoses of infectious mononucleosis due to Epstein‐Barr virus (EBV‐IM).
Snieguole Vingeliene +11 more
wiley +1 more source
In this study, WES analysis was performed on patients with DD/ID, global developmental delay, epilepsy, and multiple congenital anomalies who could not be diagnosed through karyotype, CMA, and other examinations. Nineteen pathogenic/likely pathogenic (P/LP) variants were identified in 19 patients, and with the confirmation made in the parents and ...
Nejmiye Akkus +5 more
wiley +1 more source
Oligodendrocytes interactions with glial cells and neurons in demyelinating disease [PDF]
Jiayi He +6 more
openalex +1 more source
Importance of R2 accuracy in susceptibility source separation
Abstract Purpose To examine the importance of R2 accuracy on independent paramagnetic and diamagnetic outputs from susceptibility source separation in the brain from two publicly available methods. Methods The effects of R2 errors, which translate into R2′$$ {\mathrm{R}}_2^{\prime } $$ errors, on output maps from χ‐separation and χ‐sepnet were examined
Tereza Beatriz Oliveira Assunção +6 more
wiley +1 more source
Sural/Radial Amplitude Ratio: A Useful Tool to Diagnose Non‐Length‐Dependent Neuropathy
ABSTRACT Introduction/Aims Patients with non‐length‐dependent neuropathy (NLDN) exhibit reduced sensory nerve action potential (SNAP) amplitudes in both lower and upper limbs. This study aimed to determine a threshold for the sural/radial amplitude ratio (SRAR) suggestive of NLDN.
Antoine Pegat +6 more
wiley +1 more source
Diagnostic value of NMO-IgG in demyelinating diseases of central nervous system
Xiao min Xu, You dong Wei
openalex +1 more source
The innate immune system in demyelinating disease
L. Mayo, F. Quintana, H. Weiner
semanticscholar +1 more source
As amyotrophic lateral sclerosis (ALS) clinical trials rapidly expand, efficient site operations are critical to success. A discussion among U.S. research sites identified ten practical strategies, creating a framework to strengthen infrastructure, streamline operations, and ensure sustainability of ALS clinical research sites while supporting ...
Erica Scirocco +13 more
wiley +1 more source
Gliomatosis cerebri mimicking diffuse demyelinating disease: Case Report. [PDF]
Mingomataj E +3 more
europepmc +1 more source

